Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-16 Sale | 2024-04-18 8:48 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,750 | $25.74 | $45,045 | 55,116 (Direct) | View |
| 2024-04-01 Sale | 2024-04-03 7:18 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 8,153 | $31.78 | $259,102 | 124,056 (Direct) | View |
| 2024-03-27 Sale | 2024-03-29 4:52 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 5,833 | $35.04 | $204,410 | 111,562 (Direct) | View |
| 2024-03-18 Sale | 2024-03-20 4:40 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,750 | $31.27 | $54,723 | 61,114 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 6:01 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,909 | $30 | $57,270 | 49,828 (Direct) | View |
| 2024-02-16 Sale | 2024-02-21 5:41 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,750 | $27.67 | $48,423 | 62,864 (Direct) | View |
| 2024-02-08 Sale | 2024-02-12 9:04 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 6,244 | $27.5 | $171,710 | 87,618 (Direct) | View |
| 2024-02-08 Sale | 2024-02-12 8:22 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 92,001 | $27.13 | $2,495,822 | 1,059,153 (Direct) | View |
| 2024-02-05 Sale | 2024-02-07 8:32 pm | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 24,552 | $30.05 | $737,788 | 257,043 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 4:59 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 5,696 | $18.41 | $104,851 | 1,151,154 (Direct) | View |
| 2023-12-15 Sale | 2024-01-08 4:19 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 102,303 | $19.15 | $1,959,354 | 1,156,850 (Direct) | View |
| 2024-01-04 Sale | 2024-01-05 5:44 pm | 4D Molecular Therapeutics Inc. | FDMT | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Parent GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 540,000 | $19.53 | $10,546,200 | 4,247,914 (Indirect) | View |
| 2023-06-08 Sale | 2023-06-12 6:23 pm | 4D Molecular Therapeutics Inc. | FMDT | Bizily Scott Chief Legal and HR Officer | 3,750 | $20.85 | $78,188 | 50,487 (Direct) | View |
| 2023-06-01 Sale | 2023-06-06 7:23 pm | 4D Molecular Therapeutics Inc. | FMDT | Bizily Scott Chief Legal and HR Officer | 2,247 | $18.31 | $41,143 | 20,112 (Direct) | View |
| 2023-05-09 Purchase | 2023-05-11 5:50 pm | 4D Molecular Therapeutics Inc. | FDMT | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Parent GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 850,000 | $16 | $13,600,000 | 4,787,914 (Indirect) | View |
| 2023-04-21 Sale | 2023-04-25 6:44 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 3,750 | $20 | $75,000 | 54,609 (Direct) | View |
| 2023-04-21 Sale | 2023-04-25 6:43 pm | 4D Molecular Therapeutics Inc. | FDMT | Chacko Jacob Director | 5,000 | $20.05 | $100,270 | 32,500 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 6:16 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 2,248 | $19.3 | $43,386 | 22,359 (Direct) | View |
| 2023-02-21 Sale | 2023-02-23 7:56 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 34,446 | $20.61 | $709,873 | 1,859,153 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-16 Exercise | 2024-04-18 8:48 pm | N/A 2032-06-17 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,750 | $0 | 55,116 (Direct) | View |
| 2024-04-16 Exercise | 2024-04-18 8:48 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,250 | $8.04 | 55,116 (Direct) | View |
| 2024-04-16 Exercise | 2024-04-18 8:48 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 500 | $6.49 | 55,116 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 7:18 pm | N/A 2032-06-17 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 8,153 | $0 | 124,056 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 7:18 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,996 | $15.78 | 124,056 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 7:18 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 2,916 | $8.04 | 124,056 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 7:18 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,332 | $6.49 | 124,056 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 7:18 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,909 | $20.24 | 124,056 (Direct) | View |
| 2024-03-27 Exercise | 2024-03-29 4:52 pm | N/A 2031-09-30 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 5,833 | $0 | 111,562 (Direct) | View |
| 2024-03-27 Exercise | 2024-03-29 4:52 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 5,833 | $25.98 | 111,562 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 4:40 pm | N/A 2032-06-17 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,750 | $0 | 61,114 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 4:40 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,250 | $8.04 | 61,114 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 4:40 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 500 | $6.49 | 61,114 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-29 6:01 pm | N/A 2032-06-17 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,909 | $0 | 49,828 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-29 6:01 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,909 | $20.24 | 49,828 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-21 5:41 pm | N/A 2032-06-17 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,750 | $0 | 62,864 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-21 5:41 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,250 | $8.04 | 62,864 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-21 5:41 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 500 | $6.49 | 62,864 (Direct) | View |
| 2024-02-08 Exercise | 2024-02-12 9:04 pm | N/A 2032-06-17 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 6,244 | $0 | 87,618 (Direct) | View |
| 2024-02-08 Exercise | 2024-02-12 9:04 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,996 | $15.78 | 87,618 (Direct) | View |
| 2024-02-08 Exercise | 2024-02-12 9:04 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 2,916 | $8.04 | 87,618 (Direct) | View |
| 2024-02-08 Exercise | 2024-02-12 9:04 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,332 | $6.49 | 87,618 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-07 8:32 pm | N/A 2030-11-08 | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 24,000 | $0 | 257,043 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-07 8:32 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 6,000 | $15.78 | 257,043 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-07 8:32 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 6,000 | $8.04 | 257,043 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-07 8:32 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 12,000 | $18.66 | 257,043 (Direct) | View |
Ownership(A) | 2024-02-07 7:42 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 0 | $0 | 1,595 (Direct) | View |
| 2023-12-11 Option Award | 2023-12-13 4:05 pm | N/A 2033-12-10 | 4D Molecular Therapeutics Inc. | FDMT | Mehra Uneek See Remarks | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-12-11 Option Award | 2023-12-13 4:05 pm | N/A 2033-12-10 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2023-12-11 Option Award | 2023-12-13 4:05 pm | N/A 2033-12-10 | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 590,000 | $0 | 590,000 (Direct) | View |
| 2023-12-11 Option Award | 2023-12-13 4:05 pm | N/A 2033-12-10 | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2023-12-11 Option Award | 2023-12-13 4:05 pm | N/A 2033-12-10 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz President and COO | 260,000 | $0 | 260,000 (Direct) | View |
| 2023-10-01 Option Award | 2023-10-03 4:17 pm | N/A 2033-09-30 | 4D Molecular Therapeutics Inc. | FMDT | Mehra Uneek See Remarks | 229,634 | $0 | 229,634 (Direct) | View |
| 2023-06-08 Exercise | 2023-06-12 6:23 pm | N/A 2032-08-31 | 4D Molecular Therapeutics Inc. | FMDT | Bizily Scott Chief Legal and HR Officer | 3,750 | $0 | 50,487 (Direct) | View |
| 2023-06-08 Exercise | 2023-06-12 6:23 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FMDT | Bizily Scott Chief Legal and HR Officer | 3,750 | $8.04 | 50,487 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-06 7:23 pm | N/A 2032-06-17 | 4D Molecular Therapeutics Inc. | FMDT | Bizily Scott Chief Legal and HR Officer | 1,875 | $0 | 20,112 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-06 7:23 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FMDT | Bizily Scott Chief Legal and HR Officer | 1,875 | $6.49 | 20,112 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:42 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | MILLIGAN JOHN F Director | 33,750 | $0 | 33,750 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:39 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | Tomasello Shawn Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:37 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | Miller-Rich Nancy Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:35 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | THEUER CHARLES Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:33 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | GRAY SUSANNAH Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:32 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | Chacko Jacob Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:31 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | Kasahara Noriyuki Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-05-15 Exercise | 2023-05-16 8:52 pm | N/A 2029-03-19 | 4D Molecular Therapeutics Inc. | FMDT | Moretti August J Chief Financial Officer | 3,000 | $0 | 228,105 (Direct) | View |
| 2023-05-15 Exercise | 2023-05-16 8:52 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FMDT | Moretti August J Chief Financial Officer | 3,000 | $9.41 | 228,105 (Direct) | View |
| 2023-05-02 Gift | 2023-05-04 8:09 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 600,000 | $0 | 1,859,153 (Direct) | View |
| 2023-04-21 Exercise | 2023-04-25 6:44 pm | N/A 2032-08-31 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 3,750 | $0 | 54,609 (Direct) | View |
| 2023-04-21 Exercise | 2023-04-25 6:44 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 3,750 | $8.04 | 54,609 (Direct) | View |
| 2023-04-21 Exercise | 2023-04-25 6:43 pm | N/A 2029-03-19 | 4D Molecular Therapeutics Inc. | FDMT | Chacko Jacob Director | 5,000 | $0 | 32,500 (Direct) | View |
| 2023-04-21 Exercise | 2023-04-25 6:43 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Chacko Jacob Director | 5,000 | $9.41 | 32,500 (Direct) | View |
Ownership | 2023-04-05 9:28 pm | N/A 2030-11-08 | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 0 | $0 | 320,000 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 6:16 pm | N/A 2032-06-17 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 1,875 | $0 | 22,359 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 6:16 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 1,875 | $6.49 | 22,359 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 8:26 pm | N/A 2033-02-09 | 4D Molecular Therapeutics Inc. | FDMT | Moretti August J Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 8:24 pm | N/A 2033-02-09 | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 222,000 | $0 | 222,000 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 8:23 pm | N/A 2033-02-09 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz President & COO | 75,000 | $0 | 75,000 (Direct) | View |